JP2017538734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017538734A5 JP2017538734A5 JP2017532819A JP2017532819A JP2017538734A5 JP 2017538734 A5 JP2017538734 A5 JP 2017538734A5 JP 2017532819 A JP2017532819 A JP 2017532819A JP 2017532819 A JP2017532819 A JP 2017532819A JP 2017538734 A5 JP2017538734 A5 JP 2017538734A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituents
- substituted
- hydrogen
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14199322 | 2014-12-19 | ||
| EP14199322.0 | 2014-12-19 | ||
| PCT/EP2015/080604 WO2016097347A1 (en) | 2014-12-19 | 2015-12-18 | IMIDAZOPYRIDAZINE DERIVATIVES AS ΡΙ3Κβ INHIBITORS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017538734A JP2017538734A (ja) | 2017-12-28 |
| JP2017538734A5 true JP2017538734A5 (enExample) | 2018-11-08 |
| JP6568588B2 JP6568588B2 (ja) | 2019-08-28 |
Family
ID=52134002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532819A Expired - Fee Related JP6568588B2 (ja) | 2014-12-19 | 2015-12-18 | ＰＩ３Ｋβ阻害剤としてのイミダゾピリダジン誘導体 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10087187B2 (enExample) |
| EP (1) | EP3233862B1 (enExample) |
| JP (1) | JP6568588B2 (enExample) |
| KR (1) | KR20170095239A (enExample) |
| CN (1) | CN107108634B (enExample) |
| AU (1) | AU2015366190B2 (enExample) |
| BR (1) | BR112017012930A2 (enExample) |
| CA (1) | CA2967551A1 (enExample) |
| CY (1) | CY1122381T1 (enExample) |
| DK (1) | DK3233862T3 (enExample) |
| EA (1) | EA029789B1 (enExample) |
| ES (1) | ES2761051T3 (enExample) |
| HR (1) | HRP20191550T1 (enExample) |
| HU (1) | HUE045220T2 (enExample) |
| IL (1) | IL252866B (enExample) |
| LT (1) | LT3233862T (enExample) |
| MA (1) | MA41174B1 (enExample) |
| MD (1) | MD3233862T2 (enExample) |
| ME (1) | ME03517B (enExample) |
| MX (1) | MX2017008074A (enExample) |
| PL (1) | PL3233862T3 (enExample) |
| PT (1) | PT3233862T (enExample) |
| RS (1) | RS59301B1 (enExample) |
| SI (1) | SI3233862T1 (enExample) |
| SM (1) | SMT201900509T1 (enExample) |
| WO (1) | WO2016097347A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102630111B1 (ko) | 2015-10-09 | 2024-01-25 | 얀센 파마슈티카 엔브이 | PI3Kβ 저해제로서의 퀴녹살린 및 피리도피라진 유도체 |
| DK3472160T3 (da) | 2016-06-16 | 2021-05-10 | Janssen Pharmaceutica Nv | Bicykliske pyridin-, pyrazin- og pyrimidinderivater som pi3k-beta-inhibitorer |
| AU2018246321B2 (en) | 2017-03-29 | 2021-07-29 | Janssen Pharmaceutica Nv | Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors |
| US12281119B2 (en) | 2019-02-07 | 2025-04-22 | Beigene, Ltd. | Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist |
| CN110128505A (zh) * | 2019-05-21 | 2019-08-16 | 梯尔希（南京）药物研发有限公司 | 一种戈舍瑞林杂质的合成方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
| PE20121506A1 (es) | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
| WO2008014219A2 (en) | 2006-07-24 | 2008-01-31 | Smithkline Beecham Corporation | Thiozolidinedione derivatives as p13 kinase inhibitors |
| EP2063962A2 (en) | 2006-09-07 | 2009-06-03 | Biogen Idec MA Inc. | Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| EA200901488A1 (ru) * | 2007-05-09 | 2010-04-30 | Новартис Аг | Замещенные имидазолопиридазины, как ингибиторы липидкиназы |
| US20110046127A1 (en) | 2007-11-08 | 2011-02-24 | Paolo Pevarello | Imidazopyridazines for Use as Protein Kinase Inhibitors |
| WO2009106577A1 (en) * | 2008-02-28 | 2009-09-03 | Novartis Ag | Imidazo [1,2-b] pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease |
| WO2010007099A1 (en) | 2008-07-15 | 2010-01-21 | Cellzome Limited | 2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors |
| ES2709108T3 (es) | 2009-08-17 | 2019-04-15 | Intellikine Llc | Compuestos heterocíclicos y usos de los mismos |
| DE102009049679A1 (de) * | 2009-10-19 | 2011-04-21 | Merck Patent Gmbh | Pyrazolopyrimidinderivate |
| WO2011058109A1 (en) | 2009-11-12 | 2011-05-19 | Ucb Pharma S.A. | Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors |
| UY33304A (es) | 2010-04-02 | 2011-10-31 | Amgen Inc | Compuestos heterocíclicos y sus usos |
| SI2624696T1 (sl) | 2010-10-06 | 2017-04-26 | Glaxosmithkline Llc Corporation Service Company | Benzimidazolni derivati kot inhibitorji pi3-kinaze |
| EP2678016B1 (en) | 2011-02-23 | 2016-08-10 | Intellikine, LLC | Heterocyclic compounds and uses thereof |
| WO2013028263A1 (en) | 2011-08-24 | 2013-02-28 | Glaxosmithkline Llc | Pyrazolopyrimidine derivatives as pi3 kinase inhibitors |
| US8906910B2 (en) * | 2011-12-20 | 2014-12-09 | Glaxosmithkline Llc | Imidazopyridine derivatives as PI3 kinase |
| US8778937B2 (en) | 2011-12-20 | 2014-07-15 | Glaxosmithkline Llc | Benzimidazole boronic acid derivatives as PI3 kinase inhibitors |
| TWI574962B (zh) * | 2012-11-14 | 2017-03-21 | 加拓科學公司 | 作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途 |
| GB201321734D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
-
2015
- 2015-12-18 PL PL15810784T patent/PL3233862T3/pl unknown
- 2015-12-18 HU HUE15810784A patent/HUE045220T2/hu unknown
- 2015-12-18 BR BR112017012930A patent/BR112017012930A2/pt active Search and Examination
- 2015-12-18 DK DK15810784.7T patent/DK3233862T3/da active
- 2015-12-18 MA MA41174A patent/MA41174B1/fr unknown
- 2015-12-18 ME MEP-2019-263A patent/ME03517B/me unknown
- 2015-12-18 JP JP2017532819A patent/JP6568588B2/ja not_active Expired - Fee Related
- 2015-12-18 WO PCT/EP2015/080604 patent/WO2016097347A1/en not_active Ceased
- 2015-12-18 MX MX2017008074A patent/MX2017008074A/es active IP Right Grant
- 2015-12-18 SM SM20190509T patent/SMT201900509T1/it unknown
- 2015-12-18 EP EP15810784.7A patent/EP3233862B1/en active Active
- 2015-12-18 RS RSP20191225 patent/RS59301B1/sr unknown
- 2015-12-18 CA CA2967551A patent/CA2967551A1/en active Pending
- 2015-12-18 KR KR1020177016722A patent/KR20170095239A/ko not_active Ceased
- 2015-12-18 US US15/537,551 patent/US10087187B2/en active Active
- 2015-12-18 LT LTEP15810784.7T patent/LT3233862T/lt unknown
- 2015-12-18 CN CN201580069133.7A patent/CN107108634B/zh not_active Expired - Fee Related
- 2015-12-18 EA EA201791396A patent/EA029789B1/ru not_active IP Right Cessation
- 2015-12-18 ES ES15810784T patent/ES2761051T3/es active Active
- 2015-12-18 SI SI201530855T patent/SI3233862T1/sl unknown
- 2015-12-18 PT PT158107847T patent/PT3233862T/pt unknown
- 2015-12-18 AU AU2015366190A patent/AU2015366190B2/en not_active Ceased
- 2015-12-18 MD MDE20170191 patent/MD3233862T2/ro not_active IP Right Cessation
- 2015-12-18 HR HRP20191550 patent/HRP20191550T1/hr unknown
-
2017
- 2017-06-13 IL IL252866A patent/IL252866B/en active IP Right Grant
-
2019
- 2019-10-03 CY CY20191101031T patent/CY1122381T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518059A5 (enExample) | ||
| JP2017538734A5 (enExample) | ||
| JP2018535199A5 (enExample) | ||
| WO2017205536A3 (en) | Heterocyclic inhibitors of cbp/ep300 and their use in the treatment of cancer | |
| JP2015514808A5 (enExample) | ||
| WO2015200481A8 (en) | Mnk inhibitors and methods related thereto | |
| JP2013527136A5 (enExample) | ||
| JP2018528946A5 (enExample) | ||
| JP2014518286A5 (enExample) | ||
| JP2017517565A5 (enExample) | ||
| JP2018516963A5 (enExample) | ||
| JP2014176384A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| PE20181093A1 (es) | Compuestos heterociclicos y usos de los mismos | |
| JP2016530259A5 (enExample) | ||
| JP2016515096A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2016528301A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| MX391861B (es) | Composiciones de canabinoide y usos | |
| JP2010523522A5 (enExample) | ||
| JP2016518385A5 (enExample) | ||
| JP2016503052A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| AR108265A1 (es) | Derivados de feniltriazol sustituidos con amida y usos de estos |